丝聚蛋白(FLG)检测试剂盒(酶联免疫吸附试验法)
ELISA Kit for Filaggrin (FLG)
Profilaggrin
- 编号USEJ103Hu
 - 物种Homo sapiens (Human,人) 相同的名称,不同的物种。
 - 实验方法双抗夹心
 - 反应时长3h
 - 检测范围0.312-20ng/mL
 - 灵敏度最小可检测剂量小于等于0.115ng/mL.
 - 样本类型tissue homogenates, cell lysates, cell culture supernates and other biological fluids
 - 下载 英文说明书 中文说明书
 - 规格 48T96T 96T*5 96T*10 96T*100
 - 价格 ¥ 1470 ¥ 2100 ¥ 9450 ¥ 17850 ¥ 147000
 - 欲了解实际交易价格和更多情况,请与当地经销商联系!
 
特异性
                        本试剂盒用于检测丝聚蛋白(FLG),经检测与其它相似物质无明显交叉反应。
                        由于受到技术及样本来源的限制,不可能完成对所有相关或相似物质交叉反应检测,因此本试剂盒有可能与未经检测的其它物质有交叉反应。
                    
精密度
                    精密度用样品测定值的变异系数CV表示。CV(%) = SD/mean×100 
                    批内差:取同批次试剂盒对低、中、高值定值样本进行定量检测,每份样本连续测定20 次,分别计算不同浓度样本的平均值及SD值。
                    批间差:选取3个不同批次的试剂盒分别对低、中、高值定值样本进行定量测定,每个样本使用同一试剂盒重复测定8次,分别计算不同浓度样本的平均值及SD值。
                    批内差: CV<10% 
                    批间差: CV<12% 
                
稳定性
                    经测定,试剂盒在有效期内按推荐温度保存,其活性降低率小于5%。
                    为减小外部因素对试剂盒破坏前后检测值的影响,实验室的环境条件需尽量保持一致,尤其是实验室内温度、湿度及温育条件。其次由同一实验员来进行操作可减少人为误差。
                
实验流程
                    1. 实验前标准品、试剂及样本的准备;
                            2. 加样(标准品及样本)100µL,37°C孵育1小时;
                            3. 吸弃,加检测溶液A100µL,37°C孵育1小时;
                            4. 洗板3次;
                            5. 加检测溶液B100µL,37°C孵育30分钟;
                            6. 洗板5次;
                            7. 加TMB底物90µL,37°C孵育10-20分钟;
                            8. 加终止液50µL,立即450nm读数。
                
实验原理
将丝聚蛋白(FLG)抗体包被于96孔微孔板中,制成固相载体,向微孔中分别加入标准品或标本,其中的丝聚蛋白(FLG)与连接于固相载体上的抗体结合,然后加入生物素化的丝聚蛋白(FLG)抗体,将未结合的生物素化抗体洗净后,加入HRP标记的亲和素,再次彻底洗涤后加入TMB底物显色。TMB在过氧化物酶的催化下转化成蓝色,并在酸的作用下转化成最终的黄色。颜色的深浅和样品中的丝聚蛋白(FLG)呈正相关。用酶标仪在450nm波长下测定吸光度(O.D.值),计算样品浓度。
增值服务
相关产品
| 编号 | 适用物种:Homo sapiens (Human,人) | 应用(仅供研究使用,不用于临床诊断!) | 
| URPJ103Hu02 | 丝聚蛋白(FLG)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| URPJ103Hu01 | 丝聚蛋白(FLG)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| URPJ103Hu05 | 丝聚蛋白(FLG)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| UEPJ103Hu61 | 丝聚蛋白(FLG)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| URPJ103Hu03 | 丝聚蛋白(FLG)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| URPJ103Hu04 | 丝聚蛋白(FLG)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| UPAJ103Hu01 | 丝聚蛋白(FLG)多克隆抗体 | WB | 
| UPAJ103Hu02 | 丝聚蛋白(FLG)多克隆抗体 | WB; IHC; ICC; IP. | 
| ULAJ103Hu71 | 丝聚蛋白(FLG)多克隆抗体(生物素标记) | WB; IHC; ICC. | 
| ULAJ103Hu83 | 丝聚蛋白(FLG)多克隆抗体(异硫氰酸荧光素标记) | WB; IHC; ICC; IF. | 
| ULAJ103Hu81 | 丝聚蛋白(FLG)多克隆抗体(异硫氰酸荧光素标记) | WB; IHC; ICC; IF. | 
| UMAJ103Hu21 | 丝聚蛋白(FLG)单克隆抗体 | WB; IHC; ICC; IP. | 
| USEJ103Hu | 丝聚蛋白(FLG)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. | 
| USCJ103Hu | 丝聚蛋白(FLG)检测试剂盒(化学发光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. | 
| ULMJ103Hu | 丝聚蛋白(FLG)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. | 
参考文献
| 杂志 | 参考文献 | 
| Journal of the Egyptian Women's Dermatologic Society | Filaggrin R501x and 2282del4 gene mutations and its tissue levels in patients with chronic plaque psoriasis [LWW: 01000] | 
| ?Inflammation & Allergy-Drug Targets | Neuromodulatory and Anti-Inflammatory Ingredient for Sensitive Skin: In Vitro Assessment [Pubmed:24931812] | 
| PLoS One | Protective Effects of Triphala on Dermal Fibroblasts and Human Keratinocytes [Pubmed:26731545] | 
| Journal of food biochemistry | In vitro anti-inflammatory and skin protective properties of extract comprising ceramides from de-oiled rice bran [doi:10.1111] | 
| European Journal of Pharmacology | Imiquimod-induced psoriasis-like inflammation in differentiated Human keratinocytes: Its evaluation using curcumin. [pubmed:28736282] | 
| Journal of Dermatological Science | A novel, topical, nonsteroidal, TRPV1 antagonist, PAC-14028 cream improves skin barrier function and exerts anti-inflammatory action through modulating epidermal … [Pubmed:29752146] | 
| Journal of Traditional and Complementary Medicine | In vitro anti-inflammatory and skin protective properties of Virgin coconut oil [10.1016:j.jtcme.2017.06.012] | 
| Clinical and Molecular Allergy | Markers of atopic dermatitis, allergic rhinitis and bronchial asthma in pediatric patients: correlation with filaggrin, eosinophil major basic protein and … [] | 
| Intractable & Rare Diseases Research | Filaggrin, major basic protein and leukotriene B4: Biomarkers for adult patients of bronchial asthma, atopic dermatitis and allergic rhinitis [Pubmed: 30560019] | 
| Dermatology and Therapy | Epidermal and Dermal Hallmarks of Photoaging are Prevented by Treatment with Night Serum Containing Melatonin, Bakuchiol, and Ascorbyl … [] | 
| 日本化粧品技術者会誌 | 糖化に起因する表皮機能低下に対するワイルドタイムエキスの防御効果 [] | 
| J Dermatol | Filaggrin‐gene mutation has minimal effect on the disease severity in the lesions of atopic dermatitis [34322929] | 

                    
                    
                                    
